Only 42 products have been successful so far, out of more than 800 applications.
Drug-testing for cannabis should be discontinued for nurses with a documented medical condition
The condition affects approximately nine million people globally.
An Australian study will explore the use of medical cannabis to prevent side effects of cancer treatment.
The decision from the National Institute of Health aims to improve the comparability of cannabis research.
CBD has not been a banned substance since 2017 but UK Anti-Doping still urge athletes to be cautious
The preliminary results from Project Twenty21 have been published.
The first findings from the UK’s largest medical cannabis patient study show quality of life improved by more than 50%
Epidyolex has become the first medical cannabis product to be subsidised by the Australian Government.
A line-up of leading experts will discuss how cannabis medicines can play a vital role in women’s health.